Inhibikase Therapeutics, Inc. (IKT)

Inhibikase Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	73.44	56.49	9.17	7.19	40.75	13.95
Short-Term Investments	19.74	41.05	4.09	15.86	-	-
Cash & Short-Term Investments	93.18	97.54	13.25	23.05	40.75	13.95
Cash Growth	855.76%	636.06%	-42.51%	-43.44%	192.04%	75500.11%
Receivables	-	-	-	0.04	0.11	-
Prepaid Expenses	0.91	0.8	0.74	0.16	1.5	0.05
Other Current Assets	0.08	0.11	0.22	1.12	0.11	0.77
Total Current Assets	94.16	98.45	14.21	24.37	42.47	14.78
Property, Plant & Equipment	0.12	0.15	0.3	0.57	-	-
Total Assets	94.28	98.6	14.51	24.94	42.47	14.78
Accounts Payable	1.69	0.94	0.65	1.15	1.09	1.72
Accrued Expenses	3.51	2.68	2.26	2.4	2.72	0.63
Short-Term Debt	-	-	0.38	-	-	0.04
Current Portion of Long-Term Debt	-	-	-	-	0.25	-
Current Portion of Leases	0.07	0.11	0.15	0.15	-	-
Current Unearned Revenue	-	-	-	-	-	2.33
Total Current Liabilities	8.55	3.73	3.44	3.7	4.05	4.72
Long-Term Debt	-	-	-	-	-	0.28
Long-Term Leases	-	-	0.09	0.21	-	-
Total Liabilities	8.55	3.73	3.53	3.9	4.05	5
Common Stock	0.07	0.07	0.01	0	0.03	0.01
Additional Paid-In Capital	193.76	189.25	77.87	68.8	68.21	24.81
Retained Earnings	-108.1	-94.42	-66.9	-47.87	-29.82	-15.03
Comprehensive Income & Other	-0	-0.04	0	0.1	-	-
Shareholders' Equity	85.73	94.87	10.98	21.04	38.42	9.78
Total Liabilities & Equity	94.28	98.6	14.51	24.94	42.47	14.78
Total Debt	0.07	0.11	0.62	0.35	0.25	0.32
Net Cash (Debt)	93.11	97.43	12.63	22.7	40.5	13.63
Net Cash Growth	905.54%	671.44%	-44.36%	-43.95%	197.05%	-
Net Cash Per Share	2.09	4.11	2.10	5.37	13.35	9.96
Filing Date Shares Outstanding	74.34	74.34	6.48	4.83	4.2	1.68
Total Common Shares Outstanding	74.34	69.36	6.19	4.2	4.19	1.68
Working Capital	85.61	94.72	10.77	20.68	38.42	10.06
Book Value Per Share	1.15	1.37	1.77	5.00	9.16	5.84
Tangible Book Value	85.73	94.87	10.98	21.04	38.42	9.78
Tangible Book Value Per Share	1.15	1.37	1.77	5.00	9.16	5.84
Machinery	0.12	0.1	0.1	0.24	-	-

Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q